{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:26:43Z","timestamp":1790810803955,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2023JW35"],"award-info":[{"award-number":["2023JW35"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374417"],"award-info":[{"award-number":["82374417"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174287"],"award-info":[{"award-number":["82174287"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274386"],"award-info":[{"award-number":["82274386"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejphar.2024.177033","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T04:24:07Z","timestamp":1728015847000},"page":"177033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Scoparone alleviates nonalcoholic fatty liver disease by modulating the PPAR\u03b1 signaling pathway"],"prefix":"10.1016","volume":"984","author":[{"given":"Ping","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2155-8110","authenticated-orcid":false,"given":"Haiyan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejphar.2024.177033_bib1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/er.2018-00064","article-title":"Molecular actions of PPAR\u03b1 in lipid metabolism and inflammation","volume":"39","author":"Bougarne","year":"2018","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177033_bib2","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/jcmm.14108","article-title":"Pex11a deficiency causes dyslipidaemia and obesity in mice","volume":"23","author":"Chen","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177033_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-078933","article-title":"Association between non-alcoholic fatty liver disease and risk of sarcopenia: a systematic review and meta-analysis","volume":"14","author":"Deng","year":"2024","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.ejphar.2024.177033_bib4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jhep.2024.05.020","article-title":"Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis","volume":"81","author":"Di Cola","year":"2024","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177033_bib5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3390\/genes12050645","article-title":"The role of lipid sensing nuclear receptors (PPARs and LXR) and metabolic lipases in obesity, diabetes and NAFLD","volume":"12","author":"Dixon","year":"2021","journal-title":"Genes"},{"issue":"6","key":"10.1016\/j.ejphar.2024.177033_bib6","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/s41401-022-01028-9","article-title":"Scoparone suppresses mitophagy-mediated NLRP3 inflammasome activation in inflammatory diseases","volume":"44","author":"Feng","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177033_bib7","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jhep.2021.09.007","article-title":"NAFLD-driven HCC: safety and efficacy of current and emerging treatment options","volume":"76","author":"Foerster","year":"2022","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.ejphar.2024.177033_bib8","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00125-021-05442-2","article-title":"Liver-targeting drugs and their effect on blood glucose and hepatic lipids","volume":"64","author":"Gastaldelli","year":"2021","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.ejphar.2024.177033_bib9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177033_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.molcel.2020.05.007","article-title":"Acetyl-CoA derived from hepatic peroxisomal beta-oxidation inhibits autophagy and promotes steatosis via mTORC1 activation","volume":"79","author":"He","year":"2020","journal-title":"Mol. Cell"},{"issue":"10","key":"10.1016\/j.ejphar.2024.177033_bib11","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.3390\/biomedicines9101412","article-title":"The pharmacological effects and pharmacokinetics of active compounds of Artemisia capillaris","volume":"9","author":"Hsueh","year":"2021","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.ejphar.2024.177033_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2024.177033_bib13","first-page":"1124901","article-title":"Lanzhang granules ameliorate nonalcoholic fatty liver disease by regulating the PPAR\u03b1 signaling pathway","volume":"2022","author":"Huang","year":"2022","journal-title":"Evid. Base Compl. Altern. Med."},{"key":"10.1016\/j.ejphar.2024.177033_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105170","article-title":"Scoparone as a therapeutic drug in liver diseases: pharmacology, pharmacokinetics and molecular mechanisms of action","volume":"160","author":"Hui","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177033_bib15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/2225-4110.106533","article-title":"Recent studies and progression of yin chen hao (Y\u012bn ch\u00e9n h\u0101o), a long-term used traditional Chinese medicine","volume":"3","author":"Hung","year":"2013","journal-title":"J. Tradit. Complement. Med."},{"key":"10.1016\/j.ejphar.2024.177033_bib16","doi-asserted-by":"crossref","first-page":"863756","DOI":"10.3389\/fphar.2022.863756","article-title":"Scoparone improves nonalcoholic steatohepatitis through alleviating JNK\/sab signaling pathway-mediated mitochondrial dysfunction","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejphar.2024.177033_bib17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s40265-024-02045-0","article-title":"Resmetirom: first approval","volume":"84","author":"Keam","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2024.177033_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biochi.2016.12.019","article-title":"The role and regulation of the peroxisome proliferator activated receptor alpha in human liver","volume":"136","author":"Kersten","year":"2017","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177033_bib19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.ejphar.2024.177033_bib20","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3748\/wjg.v23.i7.1125","article-title":"Therapeutic mechanism of Yin-Chen-Hao decoction in hepatic diseases","volume":"23","author":"Li","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2024.177033_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109895","article-title":"Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS\/P38\/Nrf2 axis and PI3K\/AKT\/mTOR pathway in macrophages","volume":"125","author":"Liu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2024.177033_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5805398","article-title":"Liver protective effect of fenofibrate in NASH\/NAFLD animal models","volume":"2022","author":"Mahmoudi","year":"2022","journal-title":"PPAR Res."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177033_bib23","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/hep.32324","article-title":"Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD","volume":"76","author":"Moore","year":"2022","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.ejphar.2024.177033_bib24","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.foodchem.2013.04.036","article-title":"Scoparone inhibits adipocyte differentiation through down-regulation of peroxisome proliferators-activated receptor gamma in 3T3-L1 preadipocytes","volume":"141","author":"Noh","year":"2013","journal-title":"Food Chem."},{"issue":"12","key":"10.1016\/j.ejphar.2024.177033_bib25","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/14779072.2017.1408410","article-title":"Fibrates in the management of atherogenic dyslipidemia","volume":"15","author":"Okopien","year":"2017","journal-title":"Expert Rev. Cardiovasc Ther."},{"key":"10.1016\/j.ejphar.2024.177033_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109521","article-title":"Fenofibrate, a peroxisome proliferator-activated receptor-alpha agonist, blocks steatosis and alters the inflammatory response in a mouse model of inflammation-dioxin interaction","volume":"345","author":"Olivero-Verbel","year":"2021","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177033_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/15548627.2023.2254191","article-title":"Dysfunction of autophagy in high-fat diet-induced nonalcoholic fatty liver disease","volume":"20","author":"Ren","year":"2023","journal-title":"Autophagy"},{"issue":"11","key":"10.1016\/j.ejphar.2024.177033_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188596","article-title":"Effects of peroxisome proliferator activated receptors (PPAR)-gamma and -alpha agonists on cochlear protection from oxidative stress","volume":"12","author":"Sekulic-Jablanovic","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2024.177033_bib29","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.phrs.2017.12.030","article-title":"Effect of fibrates on glycemic parameters: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"132","author":"Simental-Mendia","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2024.177033_bib30","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.17380","article-title":"Pseudotargeted lipidomics analysis of scoparone on glycerophospholipid metabolism in non-alcoholic steatohepatitis mice by LC-MRM-MS","volume":"12","author":"Song","year":"2024","journal-title":"PeerJ"},{"issue":"11","key":"10.1016\/j.ejphar.2024.177033_bib31","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1136\/gutjnl-2020-321774","article-title":"Hepatic Kruppel-like factor 16 (KLF16) targets PPARalpha to improve steatohepatitis and insulin resistance","volume":"70","author":"Sun","year":"2021","journal-title":"Gut"},{"issue":"16","key":"10.1016\/j.ejphar.2024.177033_bib32","doi-asserted-by":"crossref","first-page":"8969","DOI":"10.3390\/ijms22168969","article-title":"Mechanisms mediating the regulation of peroxisomal fatty acid beta-oxidation by PPARalpha","volume":"22","author":"Tahri-Joutey","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177033_bib33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/0960327116649675","article-title":"Influence of coumarin and some coumarin derivatives on serum lipid profiles in carbontetrachloride-exposed rats","volume":"36","author":"Tasdemir","year":"2017","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.ejphar.2024.177033_bib34","article-title":"Development and application of an UHPLC-MS\/MS method for comparative pharmacokinetic study of eight major bioactive components from yin chen hao tang in normal and acute liver injured rats. Evid.-Based complement altern","volume":"2018","author":"Wang","year":"2018","journal-title":"M\u00e9d."},{"key":"10.1016\/j.ejphar.2024.177033_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115550","article-title":"Promising traditional Chinese medicine for the treatment of cholestatic liver disease process (cholestasis, hepatitis, liver fibrosis, liver cirrhosis)","volume":"297","author":"Wei","year":"2022","journal-title":"J. Ethnopharmacol."},{"issue":"7","key":"10.1016\/j.ejphar.2024.177033_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100578","article-title":"APOA5 deficiency causes hypertriglyceridemia by reducing amounts of lipoprotein lipase in capillaries","volume":"65","author":"Yang","year":"2024","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.ejphar.2024.177033_bib37","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177033_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2024.177033_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.148027","article-title":"The kruppel-like factor (KLF) family, diseases, and physiological events","volume":"895","author":"Yuce","year":"2024","journal-title":"Gene"},{"issue":"12","key":"10.1016\/j.ejphar.2024.177033_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028502","article-title":"N-3 PUFA supplementation triggers PPAR-alpha activation and PPAR-alpha\/NF-kappaB interaction: anti-inflammatory implications in liver ischemia-reperfusion injury","volume":"6","author":"Zuniga","year":"2011","journal-title":"PLoS One"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924007234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924007234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T01:02:25Z","timestamp":1734570145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924007234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":40,"alternative-id":["S0014299924007234"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177033","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scoparone alleviates nonalcoholic fatty liver disease by modulating the PPAR\u03b1 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177033"}}